📰 Clarus Ventures News
Clarus Ventures News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Clarus Ventures. Real-time updates on events, politics, business and more.
May 3, 2024
/PRNewswire/ -- RevOpsis Therapeutics, a next-generation biopharmaceutical company spearheading innovation in ophthalmic therapies, announced today the...
January 10, 2024
Carlsbad-based genomics technology developer ChromaCode announced this morning that it has named Mark McDonough as Chairman. McDonough is the companys current CEO, and joined the company a year ago. Th
January 11, 2023
Airsupra is the first and only rescue medication approved in the US for as-needed use to reduce risk of asthma exacerbations Approval based on successful Phase III trial programme conducted
November 2, 2022
J.P. Morgan Asset Management announced the launch of a new life sciences private equity team, Life Sciences Private Capital. The new team will invest in both early and growth stage healthcare companies across multiple strategies aligned to specific market opportunities, with a focus on novel therapeutics and technologies in several target areas...
November 1, 2022
/PRNewswire/ -- J.P. Morgan Asset Management today announced the launch of a new life sciences private equity team, Life Sciences Private Capital. The new team...
May 31, 2022
Results from Phase III trials conducted by Avillion in over 4,000 patients show that PT027, a novel fixed-dose combination of albuterol and budesonide, significantly reduced the risk of a severe
May 31, 2022
/PRNewswire/ -- Avillion LLP, a drug development company focused on the co-development and financing of pharmaceutical candidates from proof-of-concept through...
May 20, 2022
Life sciences organizations and companies strengthen their leadership teams and boards with these Movers & Shakers.
May 19, 2022
/PRNewswire/ -- Odyssey Therapeutics, Inc., a biotechnology company pioneering next generation precision immunomodulators and oncology medicines, today...